CN103735961A - 石椒草咳喘片在制备抑制淋巴瘤细胞yac-1细胞增殖药物中的应用 - Google Patents
石椒草咳喘片在制备抑制淋巴瘤细胞yac-1细胞增殖药物中的应用 Download PDFInfo
- Publication number
- CN103735961A CN103735961A CN201310686375.3A CN201310686375A CN103735961A CN 103735961 A CN103735961 A CN 103735961A CN 201310686375 A CN201310686375 A CN 201310686375A CN 103735961 A CN103735961 A CN 103735961A
- Authority
- CN
- China
- Prior art keywords
- cough
- herba
- ethanol
- asthma
- boenninghauseniae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010011224 Cough Diseases 0.000 title claims abstract description 47
- 208000006673 asthma Diseases 0.000 title claims abstract description 46
- 239000003814 drug Substances 0.000 title claims abstract description 30
- 101000981253 Mus musculus GPI-linked NAD(P)(+)-arginine ADP-ribosyltransferase 1 Proteins 0.000 title claims abstract description 18
- 206010025323 Lymphomas Diseases 0.000 title claims abstract description 13
- 230000002401 inhibitory effect Effects 0.000 title abstract description 5
- 241000772044 Boenninghausenia Species 0.000 title abstract 7
- 230000035755 proliferation Effects 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 claims abstract description 25
- 229940079593 drug Drugs 0.000 claims abstract description 16
- 238000000874 microwave-assisted extraction Methods 0.000 claims abstract description 15
- 210000000582 semen Anatomy 0.000 claims abstract description 9
- 238000000194 supercritical-fluid extraction Methods 0.000 claims abstract description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 73
- 239000000284 extract Substances 0.000 claims description 23
- 238000000605 extraction Methods 0.000 claims description 21
- 239000008187 granular material Substances 0.000 claims description 18
- 241001269712 Laggera Species 0.000 claims description 15
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 11
- 230000004663 cell proliferation Effects 0.000 claims description 9
- 229940126678 chinese medicines Drugs 0.000 claims description 8
- 229920002472 Starch Polymers 0.000 claims description 7
- 230000000274 adsorptive effect Effects 0.000 claims description 7
- 239000012141 concentrate Substances 0.000 claims description 7
- 230000006837 decompression Effects 0.000 claims description 7
- 239000003480 eluent Substances 0.000 claims description 7
- 238000010828 elution Methods 0.000 claims description 7
- 238000004064 recycling Methods 0.000 claims description 7
- 229920005989 resin Polymers 0.000 claims description 7
- 239000011347 resin Substances 0.000 claims description 7
- 235000019698 starch Nutrition 0.000 claims description 7
- 239000008107 starch Substances 0.000 claims description 7
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 abstract description 12
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 abstract description 12
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 abstract description 12
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 abstract description 12
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 abstract description 12
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 abstract description 12
- 229940025878 hesperidin Drugs 0.000 abstract description 12
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 abstract description 12
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 244000001632 Acorus gramineus Species 0.000 abstract 1
- 235000013073 Acorus gramineus Nutrition 0.000 abstract 1
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 235000013719 Houttuynia cordata Nutrition 0.000 abstract 1
- 241001269715 Laggera pterodonta Species 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 241000417534 Stemona sessilifolia Species 0.000 abstract 1
- 229960004756 ethanol Drugs 0.000 description 25
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 239000000243 solution Substances 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 239000000047 product Substances 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 239000013558 reference substance Substances 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000012531 culture fluid Substances 0.000 description 3
- 229960000935 dehydrated alcohol Drugs 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- WEEMDRWIKYCTQM-UHFFFAOYSA-N 2,6-dimethoxybenzenecarbothioamide Chemical compound COC1=CC=CC(OC)=C1C(N)=S WEEMDRWIKYCTQM-UHFFFAOYSA-N 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000167880 Hirundinidae Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 229920002334 Spandex Polymers 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000010165 autogamy Effects 0.000 description 1
- FCPVYOBCFFNJFS-LQDWTQKMSA-M benzylpenicillin sodium Chemical compound [Na+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 FCPVYOBCFFNJFS-LQDWTQKMSA-M 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010219 correlation analysis Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000012738 dissolution medium Substances 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 238000004900 laundering Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000004759 spandex Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 229960002385 streptomycin sulfate Drugs 0.000 description 1
- 238000009923 sugaring Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 药物浓度(mg/ml) | 抑制率(%) |
对照组 | 0 | 0 |
1 | 5 | 10.31±7.66 |
2 | 10 | 18.69±9.71* |
3 | 15 | 28.34±12.96** |
4 | 20 | 39.64±14.03** |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310686375.3A CN103735961B (zh) | 2013-12-10 | 2013-12-10 | 石椒草咳喘片在制备抑制淋巴瘤细胞yac-1细胞增殖药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310686375.3A CN103735961B (zh) | 2013-12-10 | 2013-12-10 | 石椒草咳喘片在制备抑制淋巴瘤细胞yac-1细胞增殖药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103735961A true CN103735961A (zh) | 2014-04-23 |
CN103735961B CN103735961B (zh) | 2016-08-17 |
Family
ID=50493077
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310686375.3A Active CN103735961B (zh) | 2013-12-10 | 2013-12-10 | 石椒草咳喘片在制备抑制淋巴瘤细胞yac-1细胞增殖药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103735961B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1628770A (zh) * | 2004-08-27 | 2005-06-22 | 唐秋海 | 一种止咳平喘的药物及其制备方法 |
CN101015645A (zh) * | 2007-03-09 | 2007-08-15 | 阮玉江 | 一种治疗癌症的药物及其制备方法 |
CN102133363A (zh) * | 2011-03-22 | 2011-07-27 | 唐秋海 | 一种石椒草咳喘颗粒的质量检测方法 |
-
2013
- 2013-12-10 CN CN201310686375.3A patent/CN103735961B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1628770A (zh) * | 2004-08-27 | 2005-06-22 | 唐秋海 | 一种止咳平喘的药物及其制备方法 |
CN101015645A (zh) * | 2007-03-09 | 2007-08-15 | 阮玉江 | 一种治疗癌症的药物及其制备方法 |
CN102133363A (zh) * | 2011-03-22 | 2011-07-27 | 唐秋海 | 一种石椒草咳喘颗粒的质量检测方法 |
Non-Patent Citations (1)
Title |
---|
贾玉梅等: "基于二苯乙烯类为主要活性成分的虎杖药理作用研究进展", 《中国实验方剂学杂志》 * |
Also Published As
Publication number | Publication date |
---|---|
CN103735961B (zh) | 2016-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103566023B (zh) | 一种齿痛消炎片的制备方法及应用 | |
CN103655843B (zh) | 一种益康补元片及其制备方法和应用 | |
CN103735960A (zh) | 石椒草咳喘片在制备抑制肺癌细胞llc细胞增殖药物中的应用 | |
CN103800498B (zh) | 一种青梅感冒片的制备方法及其在抑制列腺癌细胞rm-1细胞增殖药物中的应用 | |
CN103751424A (zh) | 一种青梅感冒片的制备方法及其在抑制畸胎瘤细胞f9细胞增殖药物中的应用 | |
CN103768266A (zh) | 一种青梅感冒片的制备方法及其在抑制白血病细胞l6565细胞增殖药物中的应用 | |
CN103768211A (zh) | 一种青梅感冒片的制备方法及其在抑制淋巴瘤细胞el4细胞增殖药物中的应用 | |
CN103800499A (zh) | 一种青梅感冒片的制备方法及其在抑制黑色素瘤细胞b16细胞增殖药物中的应用 | |
CN103768262A (zh) | 一种青梅感冒片的制备方法及其在抑制骨髓瘤细胞fo细胞增殖药物中的应用 | |
CN103768263A (zh) | 一种青梅感冒片的制备方法及其在抑制脑神经瘤细胞Neuro-2a细胞增殖药物中的应用 | |
CN103768267A (zh) | 一种青梅感冒片的制备方法及其在抑制肝癌细胞h22细胞增殖药物中的应用 | |
CN103893411A (zh) | 一种青梅感冒片的制备方法及应用 | |
CN103800770A (zh) | 石椒草咳喘片在制备抑制乳腺肿瘤细胞c127细胞增殖药物中的应用 | |
CN103735961A (zh) | 石椒草咳喘片在制备抑制淋巴瘤细胞yac-1细胞增殖药物中的应用 | |
CN103768264A (zh) | 一种青梅感冒片的制备方法及其在抑制畸胎瘤细胞p19细胞增殖药物中的应用 | |
CN103800569A (zh) | 一种青梅感冒片的制备方法及其在抑制淋巴瘤细胞yac-1细胞增殖药物中的应用 | |
CN103768265A (zh) | 一种青梅感冒片的制备方法及其在抑制肺癌细胞llc细胞增殖药物中的应用 | |
CN103751350A (zh) | 一种青梅感冒片的制备方法及其在抑制白血病细胞l1210细胞增殖药物中的应用 | |
CN103768212A (zh) | 一种青梅感冒片的制备方法及其在抑制胃癌细胞mfc细胞增殖药物中的应用 | |
CN103751425A (zh) | 一种青梅感冒片的制备方法及其在抑制乳腺肿瘤细胞c127细胞增殖药物中的应用 | |
CN103751661A (zh) | 石椒草咳喘片在制备抑制胃癌细胞mfc细胞增殖药物中的应用 | |
CN104288658A (zh) | 一种阿里红咳喘片的制备方法及其在抑制小鼠骨髓瘤细胞sp2/0 细胞增殖药物中的应用 | |
CN103768207A (zh) | 一种青梅感冒片的制备方法及其在抑制肝癌细胞Hepa1-6细胞增殖药物中的应用 | |
CN103655841A (zh) | 一种益康补元片的制备方法及其在抑制小鼠淋巴样瘤细胞p388d1细胞增殖药物中的应用 | |
CN103800771A (zh) | 石椒草咳喘片在制备抑制***肉瘤细胞s-180细胞增殖药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Dai Xianhui Inventor before: Sun Bo |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160707 Address after: 266000 Qingdao Road, Chengyang District, Shandong, No. 600 the Great Wall Applicant after: Dai Xianhui Address before: 250001 Shandong Province, Ji'nan City District Court building 2303 No. 288 Applicant before: JINAN XINQIDIAN MEDICINE SCIENCE & TECHNOLOGY CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Sun Yunxia Inventor after: Zhang Jianwei Inventor before: Dai Xianhui |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170930 Address after: 253500 No. 36 Xing Xi village, zi Town, Dezhou, Shandong, Lingxian County Co-patentee after: Zhang Jianwei Patentee after: Sun Yunxia Address before: 266000 Qingdao Road, Chengyang District, Shandong, No. 600 the Great Wall Patentee before: Dai Xianhui |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180329 Address after: 226100 Fuxing Road, yuimen Town, Haimen City, Nantong, Jiangsu Province, No. 20 Patentee after: Nantong excellent art design Co., Ltd. Address before: 253500 No. 36 Xing Xi village, zi Town, Dezhou, Shandong, Lingxian County Co-patentee before: Zhang Jianwei Patentee before: Sun Yunxia |